Documentación
Documentation
Documentos de interés
ListadoInicial
lisini
- EFPIA Code on the Promotion of Prescription-Only Medicines to, and Interactions with, Healthcare Professionals (2013)
- EFPIA Code of Practice on Relationships between the Pharmaceutical Industry and Patient Organisations (2011)
- EFPIA Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations (Consolidated Version 2014)
- Código IFPMA de Buenas Prácticas (2019)
- IFPMA Our Ethos
- IFPMA - Note for Guidance on sponsorship of events and meetings
- IFPMA - Note for Guidance on fees for services
- IFPMA - Code of Practice (2019)
lisfin
lisini
- Código de Buenas Prácticas de la Industria Farmacéutica en inglés - Code of Practice for the Pharmaceutical Industry
- Criterios de utilización de hoteles aplicables a laboratorios farmacéuticos
- General Standards Applicable in Spain to Scientific and Professional Meetings
- Límites de hospitalidad en Europa
- Information related to Article 14.3 - MARKET RESEARCH STUDIES
lisfin
lisini
- Transparency and Industry Interactions with the Medical Profession - Commitment Letters published (EFPIA)
- Introducing the EFPIA Disclosure Code
- Responsible Transparency - National Associations (Letter)
- EFPIA Code - 10 Facts for Healthcare Practicioners
- EFPIA Code - Answering your Questions
- EFPIA Code - 10 Key Messages
lisfin
lisini
- Memoria Anual 2017
- Memoria Anual 2016
- Memoria Anual 2015
- Memoria Anual 2014
- Memoria Anual 2013
- Memoria Anual 2012
- Encuesta de satisfacción del sistema de autorregulación 2012
- List of Guiding Principles Promoting Good Governance in the Pharmaceutical Sector
- EFPIA and PhRMA - Joint Principles for Responsible Clinical Trial Data Sharing to Benefit Patients
- IFPMA Code Compliance Infographic
- IFPMA Code: Entrenamiento Online
- Consensus Framework for Ethical Collaboration
Lisfin
ListadoFin
Dispone de documentos adicionales en la página documentos de transparencia.